MSA Safety (NYSE:MSA) delivered third-quarter numbers that came in above market expectations, with both sales and earnings up from a year ago. The company also reaffirmed its full-year guidance in its ...
MELBOURNE, Australia and SAN FRANCISCO, May 12, 2025 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing ...